Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-10-22 | Sarah J. Schlesinger, M.D. has served as a member of our Board of Directors since February 2020. ... Dr. Schlesinger currently serves on the board of directors of Innoviva, Inc., and serves on its Compensation Committee and the Nominating/Corporate Governance Committee. ... She is a member of the Compensation Committee. ... No compensation details were provided for Dr. Schlesinger in the filing. |
| 2021-02-26 | Dr. Schlesinger, who recused themselves from the Board’s approval of the Private Placement. Dr. Schlesinger is affiliated with Innoviva and is expected to continue as a member of the Board following the closing of the Private Placement. |
| 2021-04-21 | Sarah J. Schlesinger, M.D. has served as a member of our Board of Directors since February 2020. ... Dr. Schlesinger has demonstrated leadership in her field and her substantial knowledge of our industry contributed to our conclusion that she should serve as a director. |
| 2022-03-09 | Sarah J. Schlesinger, M.D. (Director)(8) Consists of (a) 38,883 shares of Common Stock that Dr. Schlesinger has the right to acquire from us within 60 days of January 31, 2022 pursuant to the exercise of stock options, (b) 8,710,800 shares of common stock and warrants exercisable for 8,710,800 shares of common stock held by Innoviva, Inc., and (c) 7,365,969 shares of common stock and warrants exercisable for 6,153,847 shares of common stock held by Innoviva Strategic Opportunities, LLC. Innoviva, Inc and Innoviva Strategic Opportunities, LLC are entities with which Dr. Schlesinger is affiliated due to her position as a director of Innoviva, Inc. |
| 2022-10-17 | Sarah J. Schlesinger, M.D. has served as a member of our board of directors since February 2020. She also currently serves as a member of the Board of Directors of Innoviva, Inc., and serves on its Compensation Committee and is the chairperson of the Nominating/Corporate Governance Committee. Dr. Schlesinger is an Associate Professor of Clinical Investigation at Rockefeller University and Senior Attending Physician at Rockefeller University Hospital. Dr. Schlesinger was The Clinical Director of the laboratory of Dr. Ralph Steinman (Nobel Laureate 2011) from 2002 until his death in 2011. Dr. Schlesinger led the Dendritic Cell section of the Division of Retrovirology at the Walter Reed Army Institute of Research and was also a member of the Division of Infectious and Parasitic Disease Pathology at the Armed Forces Institute of Pathology from 1994 to 2002. In 2002, Dr. Schlesinger rejoined Rockefeller University and began working with the International AIDS Vaccine Initiative as a Scientist in Vaccine Research and Design. Dr. Schlesinger has been a member of Rockefeller University Hospital’s Institutional Review Board (“IRB”) (Ethics Committee) since 2003 and previously served as IRB’s vice-chairperson. In 2017 she assumed the position of chairperson of the IRB. She is currently the director of the education and training programs at Rockefeller University Center for Clinical and Translational Science. Dr. Schlesinger currently serves on the board of two non-profit organizations: the AIDS Vaccines Advocacy Coalition, and The Hastings Center, the pre-eminent center for the study of bioethics. Dr. Schlesinger served as an independent corporate director of Ariad Pharmaceuticals from 2013 until its sale to Takeda Pharmaceutical Company Limited in 2017. She also served as an independent corporate director of The Medicines Company from 2018 until its acquisition by Novartis in 2020. Dr. Schlesinger has a B.A. from Wellesley College and a M.D. from Rush Medical College in Chicago, Illinois. She trained in Anatomic Pathology at The New York Hospital where she served as Chief Resident. Dr. Schlesinger has demonstrated leadership in her field and her substantial knowledge of our industry contributed to our conclusion that she should serve as a director. |
| 2023-08-03 | Sarah J. Schlesinger, M.D. has served as a member of our board of directors since February 2020. She also currently serves as a member of the Board of Directors of Innoviva, Inc., serves as its lead independent director, and serves on its Compensation Committee and Audit Committee and is the chairperson of the Nominating/Corporate Governance Committee. |
| 2024-04-29 | Sarah J. Schlesinger, M.D. has served as a member of our board of directors since February 2020. She also currently serves as a member of the board of directors of Innoviva, Inc. and serves on its Compensation Committee and is the chairperson of the Nominating/Corporate Governance Committee. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-11 | Dr. Schlesinger is an Associate Professor of Clinical Investigation and has a M.D. from Rush Medical College. No software-related skills mentioned. |
| 2021-04-02 | Dr. Schlesinger is an Associate Professor of Clinical Investigation at Rockefeller University and Senior Attending Physician at Rockefeller University Hospital. She has a B.A. from Wellesley College and a M.D. from Rush Medical College in Chicago, Illinois. |
| 2022-03-25 | Dr. Schlesinger has a B.A. from Wellesley College and a M.D. from Rush Medical College in Chicago, Illinois. |
| 2023-04-28 | Dr. Schlesinger has a B.A. from Wellesley College and a M.D. from Rush Medical College in Chicago, Illinois. Dr. Schlesinger has demonstrated leadership in her field and her substantial knowledge of our industry contributed to our conclusion that she should serve as a director. |
| 2024-04-29 | Dr. Schlesinger has a B.A. from Wellesley College and a M.D. from Rush Medical College in Chicago, Illinois. Dr. Schlesinger has demonstrated leadership in her field and her substantial knowledge of our industry contributed to our conclusion that she should serve as a director. |
| 2025-04-08 | Dr. Schlesinger has a B.A. degree from Wellesley College and a M.D. from Rush Medical College in Chicago, Illinois. |
Data sourced from SEC filings. Last updated: 2026-02-03